Masimo Corp Files Proxy Soliciting Material
Ticker: MASI · Form: DEFA14A · Filed: May 16, 2024 · CIK: 937556
| Field | Detail |
|---|---|
| Company | Masimo CORP (MASI) |
| Form Type | DEFA14A |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 6 |
| Reading Time | 8 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, soliciting-material
TL;DR
Masimo Corp dropped proxy soliciting material, no fee needed.
AI Summary
Masimo Corporation filed a DEFA14A on May 16, 2024, indicating it is providing soliciting material under Rule 240.14a-12. This filing is not a preliminary proxy statement or definitive additional materials, but rather material used to solicit proxies. No filing fee was required for this submission.
Why It Matters
This filing indicates Masimo Corporation is actively engaging with shareholders regarding proxy matters, which could influence corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This filing is a standard procedural document for soliciting proxy materials and does not inherently indicate new risks or significant changes.
Key Players & Entities
- MASIMO CORP (company) — Registrant
- 240.14a-12 (rule) — Soliciting Material Regulation
- 0001213900-24-043934.txt (document) — Filing Identifier
FAQ
What type of filing is this DEFA14A for Masimo Corporation?
This DEFA14A filing is classified as soliciting material pursuant to Rule 240.14a-12.
When was this filing submitted to the SEC?
The filing was submitted on May 16, 2024.
Is this a preliminary proxy statement?
No, this is not a preliminary proxy statement; it is marked as soliciting material.
Was a filing fee required for this submission?
No, the filing indicates that no fee was required.
What is the standard industrial classification for Masimo Corporation?
The standard industrial classification for Masimo Corporation is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].
Filing Stats: 1,899 words · 8 min read · ~6 pages · Grade level 11.3 · Accepted 2024-05-16 06:05:20
Filing Documents
- ea0206346-defa14a_masimo.htm (DEFA14A) — 23KB
- image_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-043934.txt ( ) — 29KB
Forward-Looking Statements
Forward-Looking Statements This communication includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Masimo Corporation (“Masimo” or the “Company”), anticipated results of the stockholder votes at the 2024 Annual Meeting, the evaluation of Politan’s director nominees, a potential candidate for election to Masimo’s board of directors, a potential joint venture involving Masimo, the evaluation of a potential separation of Masimo’s Consumer Business, the expected timing for completing any joint venture or other separation of Masimo’s Consumer Business and the potential benefits of any such separation. These forward-looking statements are based on current expectations about future events affecting Masimo and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond Masimo’s control and could cause its actual results to differ materially and adversely from those expressed in its forward-looking Consumer Business, (ii) uncertainties regarding future actions that may be taken by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (iii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iv) factors discussed in the “Risk Factors” section of Masimo’s most recent reports filed with the Securities and Exchange Commission (“